Welcome to LookChem.com Sign In|Join Free
  • or
3-ethynyl-5-hydroxybenzaldehyde is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

871345-34-5

Post Buying Request

871345-34-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

871345-34-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 871345-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,3,4 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 871345-34:
(8*8)+(7*7)+(6*1)+(5*3)+(4*4)+(3*5)+(2*3)+(1*4)=175
175 % 10 = 5
So 871345-34-5 is a valid CAS Registry Number.

871345-34-5Relevant academic research and scientific papers

Simultaneous dual protein labeling using a triorthogonal reagent

Rashidian, Mohammad,Kumarapperuma, Sidath C.,Gabrielse, Kari,Fegan, Adrian,Wagner, Carston R.,Distefano, Mark D.

, p. 16388 - 16396 (2013)

Construction of heterofunctional proteins is a rapidly emerging area of biotherapeutics. Combining a protein with other moieties, such as a targeting element, a toxic protein or small molecule, and a fluorophore or polyethylene glycol (PEG) group, can imp

TRIORTHOGONAL REAGENTS FOR DUAL PROTEIN CONJUGATION

-

Page/Page column 26, (2015/05/05)

The present invention relates to triorthogonal reagents useful for site-specifically modifying a protein with two orthogonal groups that can be subsequently functionalized in a single one-pot procedure. This approach relies on the selective tagging of pro

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors

Zbinden, Katrin Groebke,Obst-Sander, Ulrike,Hilpert, Kurt,Kuehne, Holger,Banner, David W.,Boehm, Hans-Joachim,Stahl, Martin,Ackermann, Jean,Alig, Leo,Weber, Lutz,Wessel, Hans Peter,Riederer, Markus A.,Tschopp, Thomas B.,Lave, Thierry

, p. 5344 - 5352 (2007/10/03)

We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 871345-34-5